Evidence level: B
太阳活动→紫外线→皮肤合成维生素D→免疫与疾病,这条链条每一环都有真实文献支撑,但”太阳周期效应中到底有多少份额是经维生素D介导的”,至今没有一个正式的中介分析来回答。
正文
五运六气讲”天地之气,感而应之”;七政四余把行星周期与人间祸福挂钩。现代科学里最接近这条”天体→人体”通路、且每一步都能量化的,是太阳周期→紫外线→维生素D→健康结局。这条链值得认真拆,因为它是判断”天人感应”有多少生物物理真实性的试金石——可惜拆到一半,答案比想象中模糊。
环节一:太阳辐射确实是血清维生素D的主控者。 德国法兰克福(北纬50度)对 13,330 份血样做了 6.5 年追踪,发现 25(OH)D3 的季节循环几乎完全由日照时长驱动,峰值稳定出现在 8 月 16 日前后,且与甲状旁腺激素(PTH)严格负相关——阳光变少,维生素D就跌,PTH 就升(PMID 19241329)。这不是孤证:人体皮肤合成维生素D依赖 UVB(280-315nm),而 UVB 的日、季节、纬度变化规律已被辐射传输模型算得清清楚楚,高纬度冬季根本无 UVB 可合成(PMID 26547141)。所以”太阳→维生素D”这一环,物理链条是铁的。
环节二:维生素D水平与健康结局关联明确,且部分呈因果。 观察层面,德国 ESTHER 队列 9,578 人随访 9.5 年,25(OH)D 低于 30 nmol/L 者全因死亡风险比 1.75、呼吸系统死亡 2.50(PMID 23446902);美国 NHANES III 全国样本 13,331 人,最低四分位全因死亡升高 26%、人群归因风险 3.1%(PMID 18695076)。因果层面,UK Biobank 30.7 万人的非线性孟德尔随机化显示,25(OH)D 与全因死亡呈 L 形因果关联,25 vs 50 nmol/L 的死亡优势比达 1.25(PMID 36279545)。干预层面,2021 年《柳叶刀-糖尿病与内分泌学》汇总 46 个 RCT、75,541 人:补充维生素D使急性呼吸道感染风险降低 8%(OR 0.92),日服 400-1000 IU 者降幅最大(OR 0.70)(PMID 33798465)。
但中介量化的真正麻烦在于反方证据。 其一,2022 年一个 30 个 RCT、30,263 人的 meta 得出总体无效(RR 0.96),且高质量研究亚组里保护效应消失、存在发表偏倚(PMID 35215468)——干预端的结论远不如观察端漂亮。其二,2024 年 BMJ 系统综述给了一个清醒的调和:观察性研究里低 25(OH)D 与全因死亡的中等负相关成立,但 RCT 中只有单用维生素D3 时全因死亡降低 11%,且这更可能反映的是”纠正严重缺乏”而非”人人有效”(PMID 24690623)。其三,也是本课题的命门:UVR 的作用从来不只是维生素D。2017 年的系统综述明确指出,紫外线通过抗菌肽激活固有免疫、又通过光产物激活干扰素信号,存在维生素D依赖与不依赖两条平行通路,二者可互补、可拮抗(PMID 28078341)。换句话说,即便太阳周期真的影响疾病流行,你也没法把功劳全记在维生素D账上——这恰恰是中介分析最怕的”未观测混杂”。
所以”血清25(OH)D作为太阳周期-疾病关联中介变量”的量化,目前卡在这样一个位置:链条两端各自有强证据(太阳控维生素D、维生素D关联健康),中间段(太阳周期波动中有多大份额经 25(OH)D 传导)没有一篇正式中介分析。要回答它,需要的不是新机制,而是一个干净的设计:大样本队列、逐人血清 25(OH)D、按太阳周期相位(黑子数/UVB 通量)分层暴露、中介分析加因果推断。若中介比例高,则”天体周期→人体健康”有了第一条第可干预的生物通道(补维生素D即可模拟太阳);若中介比例低甚至为零,则太阳效应要么走非维生素D通路,要么本就不存在——两条路都极有价值。
证据与局限
已验证: 太阳辐射(UVB)是人群 25(OH)D 季节循环的主控因子(PMID 19241329/26547141);低 25(OH)D 与全因及呼吸/心血管死亡独立相关且呈非线性因果关联(PMID 23446902/18695076/36279545);维生素D补充对急性呼吸道感染有总体但幅度的保护效应,日服小剂量最明显(PMID 33798465)。
部分验证: “太阳周期-疾病流行”的关联存在(见母文 sunspot-latitude-health-effect-comparison),且 25(OH)D 是其中生物上最合理的候选中介;但补充剂 RCT 总体效应小、高质量研究亚组无效、存在发表偏倚(PMID 35215468/24690623)。
待验证: 太阳周期暴露经 25(OH)D 的中介比例精确值;UVR 维生素D依赖 vs 非依赖两条通路的贡献拆分;基线 25(OH)D 是否修饰”太阳周期-疾病”关联强度(缺乏者敏感、充足者免疫);中介比例的跨纬度梯度。
相关阅读
证据等级: B(太阳→维生素D、维生素D→健康结局均有 PubMed 直接支撑;”太阳周期效应经 25(OH)D 中介的比例”无直接中介分析研究,属科学类比/间接证据链)
参考文献: PMID 19241329, PMID 26547141, PMID 23446902, PMID 18695076, PMID 36279545, PMID 33798465, PMID 35215468, PMID 24690623, PMID 28078341
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
How significant is serum vitamin D as a mediating pathway for the solar cycle’s impact on health?
Evidence level: B
Sun activity → UV radiation → skin synthesis of Vitamin D → immune function and disease outcomes: each link in this chain is supported by empirical literature, yet no formal mediation analysis has definitively quantified the proportion of the “solar cycle effect” mediated specifically through Vitamin D.
Main Text
In traditional frameworks, the Five Movements and Six Qi posits that “heavenly and earthly qi respond to each other upon contact,” while the Seven Administrations and Four Remainders associate planetary cycles with human fortune and misfortune. In modern science, the pathway most analogous to this “celestial → human” trajectory, where every step is quantifiable, is Solar Cycle → UV Radiation → Vitamin D → Health Outcomes. This chain warrants rigorous dissection because it serves as a litmus test for the biological and physical validity of “heaven-human resonance.” Unfortunately, the answer becomes increasingly ambiguous as the analysis deepens.
Link 1: Solar Radiation is indeed the primary driver of serum Vitamin D levels. A longitudinal study of 13,330 blood samples in Frankfurt, Germany (latitude 50°N) over 6.5 years found that the seasonal cycle of 25(OH)D3 is driven almost entirely by daylight duration, with peaks stabilizing around August 16 and a strict negative correlation with parathyroid hormone (PTH)—as sunlight decreases, Vitamin D drops while PTH rises (PMID 19241329). This is not an isolated finding: human skin synthesis of Vitamin D relies on UVB (280-315nm), and the daily, seasonal, and latitudinal variations of UVB are precisely calculated by radiative transfer models; high-latitude winters simply lack the UVB required for synthesis (PMID 26547141). Thus, the physical link from “Sun → Vitamin D” is robust.
Link 2: Associations between Vitamin D levels and health outcomes are clear, with partial causal evidence. Observationally, the German ESTHER cohort of 9,578 individuals followed for 9.5 years showed that those with 25(OH)D below 30 nmol/L had a 1.75 risk ratio for all-cause mortality and 2.50 for respiratory death (PMID 23446902); the US NHANES III national sample of 13,331 individuals showed a 26% increase in all-cause mortality at the lowest quartile and a population attributable risk of 3.1% (PMID 18695076). Causally, a non-linear Mendelian randomization study of 307,000 individuals in the UK Biobank demonstrated a causal L-shaped association between 25(OH)D and all-cause mortality, with an odds ratio of 1.25 comparing 25 vs. 50 nmol/L (PMID 36279545). Interventionally, a 2021 meta-analysis in The Lancet Diabetes & Endocrinology aggregating 46 RCTs and 75,541 individuals found that Vitamin D supplementation reduced the risk of acute respiratory infections by 8% (OR 0.92), with the greatest reduction observed in daily doses of 400-1000 IU (OR 0.70) (PMID 33798465).
However, the true difficulty in quantifying mediation lies in counter-evidence. First, a 2022 meta-analysis of 30 RCTs involving 30,263 individuals concluded no overall effect (RR 0.96), with protective effects vanishing in high-quality subgroups and publication bias present (PMID 35215468)—conclusions at the intervention level are far less robust than those at the observational level. Second, a 2024 BMJ systematic review offered a clarifying reconciliation: while a moderate negative correlation between low 25(OH)D and all-cause mortality holds in observational studies, RCTs show only an 11% reduction in all-cause mortality when using Vitamin D3 alone, which is more likely to reflect “correcting severe deficiency” rather than universal efficacy (PMID 24690623). Third, and central to this topic: the role of UVR extends far beyond Vitamin D. A 2017 systematic review explicitly stated that UVB activates innate immunity via antimicrobial peptides and interferon signaling via photoproducts, existing parallel pathways dependent on and independent of Vitamin D, which can complement or antagonize each other (PMID 28078341). In other words, even if the solar cycle genuinely influences disease prevalence, one cannot attribute all effects solely to Vitamin D—this represents the “unobserved confounding” that mediation analysis fears most.
Therefore, quantifying serum 25(OH)D as a mediator variable linking the solar cycle to disease outcomes is currently stalled at this juncture: strong evidence exists for both ends of the chain (sun controls Vitamin D, Vitamin D associates with health), but no formal mediation analysis addresses the middle segment (what proportion of solar cycle fluctuations is transmitted via 25(OH)D). Answering this requires not a new mechanism, but a clean design: large cohort studies, individual-level serum 25(OH)D measurement, stratification by solar cycle phase (sunspot number/UVB flux), combined mediation analysis and causal inference. If the mediation proportion is high, then “celestial cycles → human health” possesses a first identifiable, modifiable biological channel (supplementing Vitamin D can simulate the sun); if low or zero, the solar effect either operates via non-Vitamin D pathways or does not exist at all—both scenarios hold significant value.
Evidence and Limitations
Verified: Solar radiation (UVB) is the primary driver of seasonal cycles in population 25(OH)D levels (PMID 19241329/26547141); low 25(OH)D is independently associated with all-cause and respiratory/cardiovascular mortality with a non-linear causal relationship (PMID 23446902/18695076/36279545); Vitamin D supplementation shows a protective effect against acute respiratory infections overall, with the most pronounced effect at low daily doses (PMID 33798465).
Partially Verified: The association between “solar cycle and disease prevalence” exists (see parent text sunspot-latitude-health-effect-comparison), and 25(OH)D is the most biologically plausible candidate mediator; however, supplement RCTs show small overall effects, high-quality subgroup analyses are null, and publication bias exists (PMID 35215468/24690623).
To Be Verified: The precise proportion of the solar cycle exposure mediated through 25(OH)D; the contribution split between Vitamin D-dependent and independent UVR pathways; whether baseline 25(OH)D modifies the strength of the “solar cycle-disease” association (susceptibility in deficient individuals, immune modulation in sufficient ones); the latitudinal gradient of the mediation proportion.
Related Reading
- Epidemiological differences in solar cycle effects across populations at different latitudes
- Seven Administrations and Four Remainders = Planetary Frequencies
- Cross-latitude multi-center direct comparison of solar cycle effects
- Five Movements and Six Qi = Climate Cycle Medicine
- Research Pool: Environment-Life Frequency Interface
Evidence Level: B (Direct PubMed support exists for Sun → Vitamin D and Vitamin D → Health Outcomes; the “proportion of solar cycle effects mediated via 25(OH)D” lacks direct mediation analysis studies, relying on structural analogy and indirect evidence chains).
References: PMID 19241329, PMID 26547141, PMID 23446902, PMID 18695076, PMID 36279545, PMID 33798465, PMID 35215468, PMID 24690623, PMID 28078341
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply